Related Experiment Video

Updated: May 11, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

[Castration in the treatment of locally advanced or metastatic prostate cancer]

Pierre Mongiat-Artus1

  • 1Service d'urologie, Inserm U728, université Paris-7, hôpital Saint-Louis, AP-HP, 75010 Paris, France. pierre.mongiat-artus@sls.aphp.fr

La Revue Du Praticien
|May 21, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: May 11, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Articles linked to this work by shared authors, journal, and citation graph.

Incisional Hernia After Minimally Invasive Radical Prostatectomy: A Systematic Review.

European urology open science·2026

p16 status and histopathological prognostic factors in penile squamous cell carcinoma.

The French journal of urology·2026

Hypofractionated radiotherapy for localized prostate cancer: From phase III evidence to real-world outcomes with or without elective pelvic nodal irradiation.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit All.

International braz j urol : official journal of the Brazilian Society of Urology·2026

A single-centre assessment of short-term functional outcomes of holmium laser enucleation vs. robot-assisted simple prostatectomy for medium and large-volume benign prostatic hyperplasia.

The French journal of urology·2026

[Specificities of oncologic surgery in elder patients].

La Revue du praticien·2026

[Alpha-gal syndrome, a new allergy that's causing a stir].

La Revue du praticien·2026

[Inflammation: effective response or vulnerability related to sex?]

La Revue du praticien·2026

[Ankylosing spondylitis is now termined as radiographic axial spondyloarthritis].

La Revue du praticien·2026

[Summary IgA nephropathy, or Berger's disease].

La Revue du praticien·2026

[Anti-VEGF treatment in age related macular degeneration].

La Revue du praticien·2026

[Producing evidence for all: geriatric oncology and the challenge of equity in health care].

La Revue du praticien·2026

Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

Frontiers in oncology·2026

Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

Frontiers in medicine·2026

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

Frontiers in immunology·2026

Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

Research (Washington, D.C.)·2026

Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

Frontiers in medical technology·2026

Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us